30 Participants NeededMy employer runs this trial

Lacrifill for Dry Eye Syndrome

PM
Overseen ByPatti Myers, COT
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Vision Innovation Centers of Pennsylvania, LLC d/b/a Eye Care Specialists
Must be taking: Antihistamines, Birth control, Lifitegrast, Cyclosporine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This research study is to see if using Lacrifill is safe, easy to use, and helpful for people who wear contact lenses but can't wear them comfortably for long. Specifically, the study aims to determine whether regular use of Lacrifill over a 2-3 month period can help people wear their contacts longer without discomfort and reduce signs and symptoms of dry eye.

Are You a Good Fit for This Trial?

Inclusion Criteria

I am taking a stable dose of antihistamines, birth control, Lifitegrast, or cyclosporine.
* Schrimers Anesthetized less than or equal to 10
* CLDEQ-8 greater than or equal to 12
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use Lacrifill regularly to assess its effect on dry eye signs and symptoms over a 2-3 month period

8-12 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Lacrifill

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: LacrifillExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vision Innovation Centers of Pennsylvania, LLC d/b/a Eye Care Specialists

Lead Sponsor

Nordic Pharma, USA

Industry Sponsor

Trials
4
Recruited
240+